United States · Bill · HR
H.R. 3925 (105th)
Prescription Drug Price Monitoring Commission Act of 1998
Introduced
21 May 1998
Last action
5 June 1998 · Referred
Status
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Sponsors
Rep. Berry, Marion [D-AR-1], Rep. Dingell, John D. [D-MI-12], Rep. Stark, Fortney Pete [D-CA-13], Rep. Clement, Bob [D-TN-5], Rep. DeFazio, Peter A. [D-OR-4], Rep. Lewis, John [D-GA-5], Rep. Furse, Elizabeth [D-OR-1], Rep. Boucher, Rick [D-VA-9], Rep. Allen, Thomas H. [D-ME-1], Rep. Blumenauer, Earl [D-OR-3], Sen. Brown, Sherrod [D-OH], Rep. Wynn, Albert Russell [D-MD-4], Rep. Thompson, Bennie G. [D-MS-2], Rep. Woolsey, Lynn C. [D-CA-6], Sen. Sanders, Bernard [I-VT], Rep. LaFalce, John J. [D-NY-29], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Olver, John W. [D-MA-1], Rep. Wamp, Zach [R-TN-3], Del. Christensen, Donna M. [D-VI-At Large], Rep. Hilliard, Earl F. [D-AL-7], Rep. Martinez, Matthew G. [D-CA-31], Rep. Baldacci, John Elias [D-ME-2], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Borski, Robert A. [D-PA-3], Rep. Pelosi, Nancy [D-CA-11], Rep. Turner, Jim [D-TX-2], Rep. Leach, James A. [R-IA-2], Rep. Ackerman, Gary L. [D-NY-5]
Subjects
Healthcare
Source updated
3 June 2026
Summary
Prescription Drug Price Monitoring Commission Act of 1998 - Establishes the Prescription Drug Price Monitoring Commission which shall conduct specified studies concerning U.S. pharmaceutical prices, including the establishment of a pharmaceutical products price review board. Terminates the Commission on a specified date. Directs the Secretary of Health and Human Services to study and report on Federal subsidies and incentives provided to the pharmaceutical industry. Amends title XIX (Medicaid) of the Social Security Act to require drug manufacturers participating in the Medicaid rebate program to report within a certain time after the end of each calendar year (currently, after each rebate period) on the average price at which the manufacturer sold each covered outpatient drug in Canada, Australia, Mexico, and the European Union countries.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 May 1998
Introduced
Referred to House Ways and Means
Source: IntroReferral
21 May 1998
Introduced
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
21 May 1998
Introduced
Introduced in House
Source: IntroReferral
21 May 1998
Introduced
Introduced in House
Source: IntroReferral
1 June 1998
Referred
Referred to the Subcommittee on Health.
Source: Committee
5 June 1998
Referred
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 21 May 1998 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 21 May 1998
Introduced in House (PDF)
Introduced in House · EN · 21 May 1998
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 21 May 1998
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Berry, Marion [D-AR-1] · D · Sponsor
- Rep. Dingell, John D. [D-MI-12] · D · Sponsor
- Rep. Stark, Fortney Pete [D-CA-13] · D · Sponsor
- Rep. Clement, Bob [D-TN-5] · D · Sponsor
- Rep. DeFazio, Peter A. [D-OR-4] · D · Sponsor
- Rep. Lewis, John [D-GA-5] · D · Sponsor
- Rep. Furse, Elizabeth [D-OR-1] · D · Sponsor
- Rep. Boucher, Rick [D-VA-9] · D · Sponsor
- Rep. Allen, Thomas H. [D-ME-1] · D · Sponsor
- Rep. Blumenauer, Earl [D-OR-3] · D · Cosponsor
- Sen. Brown, Sherrod [D-OH] · D · Cosponsor
- Rep. Wynn, Albert Russell [D-MD-4] · D · Cosponsor
- Rep. Thompson, Bennie G. [D-MS-2] · D · Cosponsor
- Rep. Woolsey, Lynn C. [D-CA-6] · D · Cosponsor
- Sen. Sanders, Bernard [I-VT] · I · Cosponsor
- Rep. LaFalce, John J. [D-NY-29] · D · Cosponsor
- Rep. Slaughter, Louise McIntosh [D-NY-25] · D · Cosponsor
- Rep. Olver, John W. [D-MA-1] · D · Cosponsor
- Rep. Wamp, Zach [R-TN-3] · R · Cosponsor
- Del. Christensen, Donna M. [D-VI-At Large] · D · Cosponsor
- Rep. Hilliard, Earl F. [D-AL-7] · D · Cosponsor
- Rep. Martinez, Matthew G. [D-CA-31] · D · Cosponsor
- Rep. Baldacci, John Elias [D-ME-2] · D · Cosponsor
- Rep. Hinchey, Maurice D. [D-NY-22] · D · Cosponsor
- Rep. Borski, Robert A. [D-PA-3] · D · Cosponsor
- Rep. Pelosi, Nancy [D-CA-11] · D · Cosponsor
- Rep. Turner, Jim [D-TX-2] · D · Cosponsor
- Rep. Leach, James A. [R-IA-2] · R · Cosponsor
- Rep. Ackerman, Gary L. [D-NY-5] · D · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/105th-congress/house-bill/3925
- Open data entity: https://api.congress.gov/v3/bill/105/hr/3925
- us · 105-hr-3925 · source updated 3 June 2026